nonproliferative diabetic retinopathy
Showing 1 - 4 of 4
Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)
Not yet recruiting
- Nonproliferative Diabetic Retinopathy
- EYP-1901
- Sham IVT
- (no location specified)
Aug 3, 2022
Nonproliferative Diabetic Retinopathy Trial in Worldwide (Intravitreal aflibercept injection [IAI], Sham)
Completed
- Nonproliferative Diabetic Retinopathy
- Intravitreal aflibercept injection [IAI]
- Sham
-
Phoenix, Arizona
- +88 more
Jul 15, 2020
Nonproliferative Diabetic Retinopathy Trial (Lucentis)
Completed
- Nonproliferative Diabetic Retinopathy
- (no location specified)
May 8, 2020
Nonproliferative Diabetic Retinopathy Trial in United States (AKB-9778, Placebo)
Completed
- Nonproliferative Diabetic Retinopathy
- AKB-9778
- Placebo
-
Phoenix, Arizona
- +52 more
Jul 24, 2019